Sequestration muzzles research and innovation

08/1/2013 | News & Observer (Raleigh, N.C.), The

Sequestration and a toxic political environment will further harm patients who have no time for delays in the development of new therapies and cures, writes John Edward Porter, chairman of Research!America board of directors. "As much as we would like to believe medical progress will continue unabated, we must accept the inevitable consequence of sequestration and other federal actions that muzzle research and innovation -– needless deaths, economic decline and challenges to our global competitiveness," Porter writes. Ideological battles drain federal research budgets that sustain basic research and private-sector innovation, while collaboration is discouraged under the current systems, which hampers innovation, Porter writes.

View Full Article in:

News & Observer (Raleigh, N.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA